Cancer scientists in Britain are launching what they call the world’s first “Darwinian” drug development program in a bid to get ahead of cancer’s ability to become resistant to even the newest treatments and recur in many patients.
Uncover the stories others won’t tell. Subscribe now for exclusive access
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted